![](/img/cover-not-exists.png)
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients
Mösges, R., Koch, A.F., Raskopf, E., Singh, J., Shah-Hosseini, K., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S.R., Shamji, M.H.Language:
english
Journal:
Allergy
DOI:
10.1111/all.13392
Date:
January, 2018
File:
PDF, 902 KB
english, 2018